{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:01:36Z","timestamp":1770415296148,"version":"3.49.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s40618-014-0186-2","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T17:19:51Z","timestamp":1416590391000},"page":"269-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cross-sex hormone therapy for gender dysphoria"],"prefix":"10.1007","volume":"38","author":[{"given":"B.","family":"Fabris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"186_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","volume":"13","author":"E Coleman","year":"2011","unstructured":"Coleman E, Bockting W, Botzer M et al (2011) Standards of care for health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism 13:165\u2013232","journal-title":"Int J Transgenderism"},{"key":"186_CR2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual on mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual on mental disorders, 5th edn. American Psychiatric Publishing, Washington, DC","edition":"5"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","volume":"94","author":"WC Hembree","year":"2009","unstructured":"Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA et al (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132\u20133154","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jsm.12413","volume":"11","author":"AD Fisher","year":"2014","unstructured":"Fisher AD, Castellini G, Bandini E et al (2014) Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. J Sex Med 11:709\u2013719","journal-title":"J Sex Med"},{"key":"186_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.med.0000436187.95351.a9","volume":"20","author":"MC Meriggiola","year":"2013","unstructured":"Meriggiola MC, Berra M (2013) Safety of hormonal treatment in transgenders. Curr Opin Endocrinol Diabetes Obes 20:565\u2013569","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"186_CR6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1743-6109.2012.03006.x","volume":"10","author":"AD Fisher","year":"2013","unstructured":"Fisher AD, Bandini E, Casale H et al (2013) Sociodemographic and clinical features of gender identity disorder: an italian multicentric evaluation. J Sex Med 10:408\u2013419","journal-title":"J Sex Med"},{"key":"186_CR7","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1743-6109.2009.01687.x","volume":"7","author":"AD Fisher","year":"2010","unstructured":"Fisher AD, Bandini E, Ricca V et al (2010) Dimensional profiles of male to female gender identity disorder: an exploratory research. J Sex Med 7:2487\u20132498","journal-title":"J Sex Med"},{"key":"186_CR8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10508-007-9307-8","volume":"38","author":"E Gomez-Gil","year":"2009","unstructured":"Gomez-Gil E, Trilla A, Salamero M, Godas T, Valdes M (2009) Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch Sex Behav 38:378\u2013392","journal-title":"Arch Sex Behav"},{"key":"186_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.med.0000436182.42966.31","volume":"20","author":"IE Antonio De","year":"2013","unstructured":"De Antonio IE, Gomez-Gil E, GIDSEEN Group (2013) Coordination of healthcare for transsexual persons: a multidisciplinary approach. Curr Opin Endocrinol Diabetes Obes 20:585\u2013591","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"186_CR10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.med.0000436188.95351.4d","volume":"20","author":"IH Gardner","year":"2013","unstructured":"Gardner IH, Safer JD (2013) Progress on the road to better medical care for transgender patients. Curr Opin Endocrinol Diabetes Obes 20:553\u2013558","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"186_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","volume":"47","author":"PJ Kesteren van","year":"1997","unstructured":"van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 47:337\u2013342","journal-title":"Clin Endocrinol (Oxf)"},{"key":"186_CR12","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","volume":"9","author":"K Wierckx","year":"2012","unstructured":"Wierckx K, Mueller S, Weyers S et al (2012) Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 9:2641\u20132651","journal-title":"J Sex Med"},{"key":"186_CR13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"Asscheman H, Giltay EJ, Megens JAJ, de Ronde W, van Trotsenburg MAA, Gooren LJG (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164:635\u2013642","journal-title":"Eur J Endocrinol"},{"key":"186_CR14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","volume":"169","author":"K Wierckx","year":"2013","unstructured":"Wierckx K, Elaut E, Declercq E et al (2013) Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol 169:471\u2013478","journal-title":"Eur J Endocrinol"},{"key":"186_CR15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF03345758","volume":"32","author":"A Godano","year":"2009","unstructured":"Godano A, Maggi M, Jannini E et al (2009) SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders. J Endocrinol Invest 32:857\u2013864","journal-title":"J Endocrinol Invest"},{"key":"186_CR16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1743-6109.2010.02130.x","volume":"8","author":"A Inoubli","year":"2011","unstructured":"Inoubli A, De Cuypere G, Rubens R et al (2011) Karyotyping, is it worthwhile in transsexualism? J Sex Med 8:475\u2013478","journal-title":"J Sex Med"},{"key":"186_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1542-2011.2011.00037.x","volume":"56","author":"K Steinle","year":"2011","unstructured":"Steinle K (2011) Hormonal management of the female-to-male transgender patient. J Midwifery Womens Health 56:293\u2013302","journal-title":"J Midwifery Womens Health"},{"key":"186_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/PHAR.1006","volume":"32","author":"EL Knezevich","year":"2012","unstructured":"Knezevich EL, Viereck LK, Drincic AT (2012) Medical management of adult transsexual persons. Pharmacotherapy 32:54\u201366","journal-title":"Pharmacotherapy"},{"key":"186_CR19","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1517\/14656566.6.10.1751","volume":"6","author":"L Harle","year":"2005","unstructured":"Harle L, Basaria S, Dobs AS (2005) Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother 6:1751\u20131759","journal-title":"Expert Opin Pharmacother"},{"key":"186_CR20","first-page":"4500","volume":"85","author":"RS Swerdloff","year":"2000","unstructured":"Swerdloff RS, Wang C, Cunningham G et al (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 85:4500\u20134510","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.ijir.3901366","volume":"19","author":"A Seftel","year":"2007","unstructured":"Seftel A (2007) Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents. Int J Impot Res 19:2\u201324","journal-title":"Int J Impot Res"},{"key":"186_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0009922806296651","volume":"46","author":"SK Bhowmick","year":"2007","unstructured":"Bhowmick SK, Ricke T, Rettig KR (2007) Sexual precocity in a 16-month-old boy induced by indirect topical exposure to testosterone. Clin Pediatr Phila 46:540\u2013543","journal-title":"Clin Pediatr Phila"},{"issue":"Suppl 2","key":"186_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000087751","volume":"64","author":"L Gooren","year":"2005","unstructured":"Gooren L (2005) Hormone treatment of the adult transsexual patient. Horm Res 64(Suppl 2):31\u201336","journal-title":"Horm Res"},{"key":"186_CR24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2164\/jandrol.112.017020","volume":"33","author":"A Yin","year":"2012","unstructured":"Yin A, Alfadhli E, Htun M et al (2012) Dietary fat modulates the testosterone pharmacokinetics of a new self emulsifying formulation of oral testosterone undecanoate in hypogonadal men. J Androl 33:1282\u20131290","journal-title":"J Androl"},{"key":"186_CR25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","volume":"364","author":"LJ Gooren","year":"2011","unstructured":"Gooren LJ (2011) Clinical practice. Care of transsexual persons. N Engl J Med 364:1251\u20131257","journal-title":"N Engl J Med"},{"key":"186_CR26","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","volume":"88","author":"AW Toorians","year":"2003","unstructured":"Toorians AW, Thomassen MC, Zweegman S et al (2003) Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88:5723\u20135729","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR27","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","volume":"88","author":"E Moore","year":"2003","unstructured":"Moore E, Wisniewski A, Dobs A (2003) Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88:3467\u20133473","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","volume":"93","author":"LJ Gooren","year":"2008","unstructured":"Gooren LJ, Giltay EJ, Bunck MC (2008) Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 93:19\u201325","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","volume":"38","author":"H Asscheman","year":"1989","unstructured":"Asscheman H, Gooren LJG, Eklund PLE (1989) Mortality and morbidity in transsexual patients with crossgender hormone treatment. Metabolism 38:869\u2013873","journal-title":"Metabolism"},{"key":"186_CR30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","volume":"113","author":"R Dittrich","year":"2005","unstructured":"Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A (2005) Endocrine treatment of male-tofemale transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 113:586\u2013592","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"186_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","volume":"15","author":"WJ Meyer 3rd","year":"1986","unstructured":"Meyer WJ 3rd, Webb A, Stuart CA, Finkelstein JW, Lawrence B, Walker PA (1986) Physical and hormonal evaluation of transsexual patients: a longitudinal study. Arch Sex Behav 15:121\u2013138","journal-title":"Arch Sex Behav"},{"key":"186_CR32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. J Am Med Assoc 288:321\u2013333","journal-title":"J Am Med Assoc"},{"key":"186_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4158\/EP.9.1.12","volume":"9","author":"V Tangpricha","year":"2003","unstructured":"Tangpricha V, Ducharme SH, Barber TW, Chipkin SR (2003) Endocrinologic treatment of gender identity disorders. Endocr Pract 9:12\u201321","journal-title":"Endocr Pract"},{"key":"186_CR34","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1210\/jc.2007-0620","volume":"92","author":"M Zitzmann","year":"2007","unstructured":"Zitzmann M, Nieschlag E (2007) Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 92:3844\u20133853","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0015-0282(16)49155-7","volume":"45","author":"H Amirikia","year":"1986","unstructured":"Amirikia H, Savoy-Moore RT, Sundareson AS, Moghissi KS (1986) The effects of long-term androgen treatment on the ovary. Fertil Steril 45:202\u2013208","journal-title":"Fertil Steril"},{"key":"186_CR36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","volume":"62","author":"W Futterweit","year":"1986","unstructured":"Futterweit W, Deligdisch L (1986) Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 62:16\u201321","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1330467","volume":"133","author":"R Choudhry","year":"1992","unstructured":"Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ (1992) Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 133:467\u2013475","journal-title":"J Endocrinol"},{"key":"186_CR38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198304283081701","volume":"308","author":"SP Marynick","year":"1983","unstructured":"Marynick SP, Chakmakjian ZH, McCaffree DL, Herndon JH Jr (1983) Androgen excess in cystic acne. N Engl J Med 308:981\u2013986","journal-title":"N Engl J Med"},{"key":"186_CR39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00403-012-1265-x","volume":"304","author":"JJ Lai","year":"2012","unstructured":"Lai JJ, Chang P, Lai KP, Chen L, Chang C (2012) The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res 304:499\u2013510","journal-title":"Arch Dermatol Res"},{"key":"186_CR40","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/jcem.85.8.6710","volume":"85","author":"EJ Giltay","year":"2000","unstructured":"Giltay EJ, Gooren LJ (2000) Effects of sex steroid deprivation\/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 85:2913\u20132921","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/joe.0.1800107","volume":"180","author":"EJ Giltay","year":"2004","unstructured":"Giltay EJ, Toorians AW, Sarabdjitsingh AR, de Vries NA, Gooren LJ (2004) Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. J Endocrinol 180:107\u2013112","journal-title":"J Endocrinol"},{"key":"186_CR42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1743-6109.2007.00646.x","volume":"5","author":"LJ Gooren","year":"2008","unstructured":"Gooren LJ, Giltay EJ (2008) Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females. J Sex Med 5:765\u2013776","journal-title":"J Sex Med"},{"key":"186_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-11-0250","volume":"165","author":"K Wierckx","year":"2011","unstructured":"Wierckx K, Elaut E, Van Caenegem E, Van De Peer F, Dedecker D, Van Houdenhove E (2011) Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration. Eur J Endocrinol 165:331\u2013337","journal-title":"Eur J Endocrinol"},{"key":"186_CR44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/0092623X.2012.736920","volume":"39","author":"A Costantino","year":"2013","unstructured":"Costantino A, Cerpolini S, Alvisi S, Morselli PG, Venturoli S, Meriggiola MC (2013) A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery. J Sex Marital Ther 39:321\u2013335","journal-title":"J Sex Marital Ther"},{"key":"186_CR45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1369\/jhc.6A6928.2006","volume":"54","author":"MH Slagter","year":"2006","unstructured":"Slagter MH, Gooren LJ, Scorilas A, Petraki CD, Diamandis EP (2006) Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. J Histochem Cytochem 54:905\u2013910","journal-title":"J Histochem Cytochem"},{"key":"186_CR46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/humrep\/del474","volume":"22","author":"T Baba","year":"2007","unstructured":"Baba T, Endo T, Honnma H et al (2007) Association between polycystic ovary syndrome and female-to-male transsexuality. Hum Reprod 22:1011\u20131016","journal-title":"Hum Reprod"},{"key":"186_CR47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","volume":"20","author":"M Grynberg","year":"2010","unstructured":"Grynberg M, Fanchin R, Dubost G et al (2010) Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online 20:553\u2013558","journal-title":"Reprod Biomed Online"},{"key":"186_CR48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.yfrne.2009.03.004","volume":"30","author":"H Shi","year":"2009","unstructured":"Shi H, Seeley RJ, Clegg DJ (2009) Sexual differences in the control of energy homeostasis. Front Neuroendocrinol 30:396\u2013404","journal-title":"Front Neuroendocrinol"},{"key":"186_CR49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","volume":"21","author":"BL Wajchenberg","year":"2000","unstructured":"Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697\u2013738","journal-title":"Endocr Rev"},{"key":"186_CR50","first-page":"E317","volume":"276","author":"JM Elbers","year":"1999","unstructured":"Elbers JM, Asscheman H, Seidell JC, Gooren LJ (1999) Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol 276:E317\u2013E325","journal-title":"Am J Physiol"},{"key":"186_CR51","first-page":"1260","volume":"80","author":"W Futterweit","year":"1980","unstructured":"Futterweit W (1980) Endocrine management of transsexual. Hormonal profiles of serum prolactin, testosterone, and estradiol. N Y State J Med 80:1260\u20131264","journal-title":"N Y State J Med"},{"key":"186_CR52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.2003.01821.x","volume":"59","author":"A Levy","year":"2003","unstructured":"Levy A, Crown A, Reid R (2003) Endocrine intervention for transsexuals. Clin Endocrinol (Oxf) 59:409\u2013418","journal-title":"Endocrine intervention for transsexuals. Clin Endocrinol (Oxf)"},{"key":"186_CR53","doi-asserted-by":"crossref","unstructured":"Asscheman H, Gooren LJG (1993) Hormone treatment in transsexuals. Transgender care health information archive. http:\/\/www.tgcare.com","DOI":"10.1300\/J056v05n04_03"},{"key":"186_CR54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00735221","volume":"411","author":"A Sapino","year":"1987","unstructured":"Sapino A, Pagani A, Godano A, Bussolati G (1987) Effects of estrogens on the testis of transsexuals: a pathological and immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 411:409\u2013414","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"186_CR55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2559.1988.tb01961.x","volume":"12","author":"ID Venizelos","year":"1988","unstructured":"Venizelos ID, Paradinas FJ (1988) Testicular atrophy after oestrogen therapy. Histopathology 12:451\u2013454","journal-title":"Histopathology"},{"key":"186_CR56","first-page":"4290","volume":"81","author":"B Jin","year":"1996","unstructured":"Jin B, Turner L, Walters WA, Handelsman DJ (1996) The effects of chronic high dose androgen or estrogen treatment on the human prostate (corrected). J Clin Endocrinol Metab 81:4290\u20134295","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR57","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bone.2008.09.001","volume":"43","author":"B Lapauw","year":"2008","unstructured":"Lapauw B, Taes Y, Simoens S et al (2008) Body composition, volumetric and areal bone parameters in male-tofemale transsexual persons. Bone 43:1016\u20131021","journal-title":"Bone"},{"key":"186_CR58","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","volume":"310","author":"R Vigen","year":"2013","unstructured":"Vigen R, O\u2019Donnell CI, Baron AE et al (2013) Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. J Am Med Assoc 310:1829\u20131836","journal-title":"J Am Med Assoc"},{"key":"186_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","volume":"72","author":"MB Elamin","year":"2010","unstructured":"Elamin MB, Garcia MZ, Murad MH, Erwin PJ, Montori VM (2010) Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses. Clin Endocrinol (Oxf) 72:1\u201310","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"186_CR60","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s11739-013-0914-1","volume":"8","author":"G Tirabassi","year":"2013","unstructured":"Tirabassi G, Gioia A, Giovannini L et al (2013) Testosterone and cardiovascular risk. Intern Emerg Med 8(Suppl 1):S65\u2013S69","journal-title":"Intern Emerg Med"},{"key":"186_CR61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2009.04.016","volume":"207","author":"TH Jones","year":"2009","unstructured":"Jones TH, Saad F (2009) The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 207:318\u2013327","journal-title":"Atherosclerosis"},{"key":"186_CR62","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","volume":"34","author":"TH Jones","year":"2011","unstructured":"Jones TH, Arver S, Behre HM et al (2011) Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study). Diabetes Care 34:828\u2013837","journal-title":"Diabetes Care"},{"key":"186_CR63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-09-0092","volume":"161","author":"A Mathur","year":"2009","unstructured":"Mathur A, Malkin C, Saeed B, Muthusamy R, Jones TH, Channer K (2009) Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. Eur J Endocrinol 161:443\u2013449","journal-title":"Eur J Endocrinol"},{"key":"186_CR64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem.83.2.4574","volume":"83","author":"EJ Giltay","year":"1998","unstructured":"Giltay EJ, Hoogeveen EK, Elbers JM et al (1998) Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 83:550\u2013553","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1018638715498","volume":"27","author":"W Futterweit","year":"1998","unstructured":"Futterweit W (1998) Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav 27:209\u2013226","journal-title":"Arch Sex Behav"},{"key":"186_CR66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","volume":"11","author":"L Xu","year":"2013","unstructured":"Xu L, Freeman G, Cowling BJ, Schooling CM (2013) Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 11:108","journal-title":"BMC Med"},{"key":"186_CR67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-08-0289","volume":"159","author":"A Mueller","year":"2008","unstructured":"Mueller A, Gooren L (2008) Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 159:197\u2013202","journal-title":"Eur J Endocrinol"},{"key":"186_CR68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clbc.2011.06.006","volume":"11","author":"T Shao","year":"2011","unstructured":"Shao T, Grossbard ML, Klein P (2011) Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer 11:417\u2013419","journal-title":"Clin Breast Cancer"},{"key":"186_CR69","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G, Endogenous H, Breast Cancer Collaborative G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606\u2013616","journal-title":"J Natl Cancer Inst"},{"key":"186_CR70","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.gme.0000177707.81191.4d","volume":"12","author":"North American Menopause","year":"2005","unstructured":"North American Menopause (2005) S. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause 12:496\u2013511","journal-title":"Menopause"},{"key":"186_CR71","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","volume":"7","author":"A Balen","year":"2001","unstructured":"Balen A (2001) Polycystic ovary syndrome and cancer. Hum Reprod Update 7:522\u2013525","journal-title":"Hum Reprod Update"},{"key":"186_CR72","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/0046-8177(94)90037-X","volume":"25","author":"S Chadha","year":"1994","unstructured":"Chadha S, Pache TD, Huikeshoven JM, Brinkmann AO, van der Kwast TH (1994) Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. Hum Pathol 25:1198\u20131204","journal-title":"Hum Pathol"},{"key":"186_CR73","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1095\/biolreprod20.2.261","volume":"20","author":"SG Hillier","year":"1979","unstructured":"Hillier SG, Ross GT (1979) Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol Reprod 20:261\u2013268","journal-title":"Biol Reprod"},{"key":"186_CR74","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/jbmr.5650111121","volume":"11","author":"P Lips","year":"1996","unstructured":"Lips P, van Kesteren PJ, Asscheman H, Gooren LJ (1996) The effect of androgen treatment on bone metabolism in female-to-male transsexuals. J Bone Miner Res 11:1769\u20131773","journal-title":"J Bone Miner Res"},{"key":"186_CR75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2265.1998.00396.x","volume":"48","author":"P Kesteren van","year":"1998","unstructured":"van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J (1998) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol Oxf 48:347\u2013354","journal-title":"Clin Endocrinol Oxf"},{"key":"186_CR76","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","volume":"362","author":"PY Scarabin","year":"2003","unstructured":"Scarabin PY, Oger E, Plu-Bureau G, Estrogen & Group THRS (2003) Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 362:428\u2013432","journal-title":"Lancet"},{"key":"186_CR77","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","volume":"58","author":"JM Elbers","year":"2003","unstructured":"Elbers JM, Giltay EJ, Teerlink T et al (2003) Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol Oxf 58:562\u2013571","journal-title":"Clin Endocrinol Oxf"},{"key":"186_CR78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.maturitas.2009.01.009","volume":"62","author":"R Wilson","year":"2009","unstructured":"Wilson R, Spiers A, Ewan J, Johnson P, Jenkins C, Carr S (2009) Effects of high dose oestrogen therapy on circulating inflammatory markers. Maturitas 62:281\u2013286","journal-title":"Maturitas"},{"key":"186_CR79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0037-1614026","volume":"84","author":"EJ Giltay","year":"2000","unstructured":"Giltay EJ, Gooren LJ, Emeis JJ, Kooistra T, Stehouwer CD (2000) Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men. Thromb Haemost 84:359\u2013360","journal-title":"Thromb Haemost"},{"key":"186_CR80","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","volume":"99","author":"YC Tai","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99:1811\u20131814","journal-title":"J Natl Cancer Inst"},{"key":"186_CR81","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2265.1988.tb03849.x","volume":"28","author":"H Asscheman","year":"1988","unstructured":"Asscheman H, Gooren LJ, Assies J, Smits JP, de Slegte R (1988) Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals. Clin Endocrinol Oxf 28:583\u2013588","journal-title":"Clin Endocrinol Oxf"},{"key":"186_CR82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ando.2007.03.008","volume":"68","author":"S Christin-Maitre","year":"2007","unstructured":"Christin-Maitre S, Delemer B, Touraine P, Young J (2007) Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. Ann Endocrinol Paris 68:106\u2013112","journal-title":"Ann Endocrinol Paris"},{"key":"186_CR83","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2265.1985.tb01081.x","volume":"22","author":"LJ Gooren","year":"1985","unstructured":"Gooren LJ, Harmsen-Louman W, van Kessel H (1985) Follow-up of prolactin levels in long-term oestrogentreated male-to-female transsexuals with regard to prolactinoma induction. Clin Endocrinol Oxf 22:201\u2013207","journal-title":"Clin Endocrinol Oxf"},{"key":"186_CR84","doi-asserted-by":"crossref","unstructured":"Gooren L, Lips P (2014) Conjectures concerning cross-sex hormone treatment of aging transsexual persons. J Sex Med (in press)","DOI":"10.1111\/jsm.12563"},{"key":"186_CR85","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/aja.2012.89","volume":"14","author":"MC Meriggiola","year":"2012","unstructured":"Meriggiola MC, Berra M (2012) Long-term cross-sex hormone treatment is safe in transsexual subjects. Asian J Androl 14:813\u2013814","journal-title":"Asian J Androl"},{"key":"186_CR86","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/jsm.12319","volume":"10","author":"LJ Gooren","year":"2013","unstructured":"Gooren LJ, van Trotsenburg MA, Giltay EJ, van Diest PJ (2013) Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med 10:3129\u20133134","journal-title":"J Sex Med"},{"key":"186_CR87","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.med.0000436183.34931.a5","volume":"20","author":"R Ettner","year":"2013","unstructured":"Ettner R (2013) Care of the elderly transgender patient. Curr Opin Endocrinol Diabetes Obes 20:580\u2013584","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"186_CR88","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1473-3099(12)70315-8","volume":"13","author":"SD Baral","year":"2013","unstructured":"Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyer C (2013) Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 13:214\u2013222","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0186-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0186-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T18:17:08Z","timestamp":1566065828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0186-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}